机译:甲状腺乳头状微癌宫颈淋巴结转移的危险因素:1587名患者的研究
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[2]Department of Head and Neck, Shanxi Cancer Hospital, Taiyuan 030013, China;
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[3]Department of Ultrasound, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin''s Clinical Research Center for Cancer, Tianjin 300060, China;
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[1]Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin''s Tianjin Clinical Research Center for Cancer, Tianjin 300060, China;
[4]Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University, Shanghai 200240, China;
PTMC; risk factors; CLNM; LLNM; BRAFV600E mutation;